Improvement of sensoneurinal hearing loss in a patient with Muckle-Wells syndrome treated with Anakinra;Rückbildung der schwerhörigkeit bei einer patientin mit Muckle-Wells-Syndrom unter therapie mit Anakinra

Klinische Padiatrie

Volumn 222, Issue 4, 2010, Pages 266-268

  Klein, A K ^a   Horneff, G ^a  

^a Asklepios Clinic Sankt Augustin   (Germany)

Author keywords

Anakinra; Muckle Wells syndrome; periodic fever syndromes; sensoneurinal hearing loss

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ABNORMAL LABORATORY RESULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; COXITIS; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; FEVER; HUMAN; MUCKLE WELLS SYNDROME; OSTEITIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SCHOOL CHILD; URTICARIA; UVEITIS;

ANTIRHEUMATIC AGENTS; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; CHILD; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; DNA MUTATIONAL ANALYSIS; FEMALE; HEARING LOSS, HIGH-FREQUENCY; HETEROZYGOTE DETECTION; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LONG-TERM CARE;

EID: 77951627028     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1239527     Document Type: Article

References (17)

1. Agostini L, et al. NALP3 forms an IL-1-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004 20 319-325
2. Aksentijevich I, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 2002 46 3340-3348
3. Brockow I, et al. Bundesweites Neugeborenen-Hörscreening Erfahrungen aus dem bayerischen Modellprojekt. Klin Padiatr 2009 221 103
4. Dode C, et al. New mutations of CIAS 1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am J Hum genet 2002 70 1498-1506
5. Feldmann J, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002 71 198-203
6. Gillmore J, et al. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. The Lancet 2001 358 (9275) 24-29
7. Goldbach-Mansky R, et al. Neonatal-onset multisystem inflammatory disease responsive to Interleukin-1 inhibition. N Engl J Med. 2006 355 (6) 581-592
8. Hawkins PN, et al. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004 50 607-612
9. Hoffman HM, et al. Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies. Arthritis Rheum 2008 Aug 58 (8) 2443-2452
10. Lachmann HJ, et al Canakinumab in CAPS Study Group. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 2009 360 (23) 2416-2425
11. Leslie KS, et al. Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations. Arch Dermatol 2006 142 1591-1597
12. Maksimovic L, et al. New CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromes. Rheumatology 2008 47 309-310
13. Mirault T, et al. Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra. Arthritis Rheum 2006 54 1697-1700
14. Muckle TJ, Wells M. Urticaria, deafness and amyloidosis: a new heredofamilial syndrome. QJM 1962 31 235-248
15. Yamada T. Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness. Clin Chem Lab Med. 1999 37 381-388
16. Yamazaki T, et al. Anakinra improves sensory deafness in a japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasome. Arthritis Rheum 2008 58 864-868
17. Winterhalter S, Niehues T. TNF- blocking therapy or conventional immunosupressive drugs in the therapy of children with uveitis?. An evidence based approach. Klin Padiatr 2008 220 342-347